Webinar – Eric Vivier – Harnessing innate immunity in cancer therapy and beyond

Monday 1st March 2021 at Online Webinar

New therapies that promote antitumor immunity have been recently developed. Most of these immunomodulatory approaches have focused on enhancing T-cell responses. Although these therapies have led to unprecedented successes, only a minority of cancer patients benefit from them, highlighting the need to identify new cells and molecules that could be exploited in the next generation of immunotherapy. Given the crucial role of innate immune responses in immunity, harnessing these responses opens up new possibilities for long-lasting, multilayered tumor control. We will present innovative anti-tumor therapies based on the manipulation of the innate immune system. In addition, given the urgent need for effective treatments for pneumonia in patients with COVID-19, the elucidation of the immune responses that occur during the course of COVID-19 could lead to the repurposing of approved immunomodulatory drugs and candidate drugs that have already been tested in clinical trials. Along this line, we will present our results indicating the association of COVID-19 inflammation with activation of the C5a–C5aR1 axis.

PRESENTER

Éric Vivier, DVM, PhD completed his post-doctoral training at Harvard Medical School, then joined Aix-Marseille University as professor at the Centre d’Immunologie de Marseille-Luminy (CIML) in 1993 before becoming its director from 2008 to 2017. He is Professor of Immunology at Aix-Marseille University and at the Public Hospital of Marseille (AP-HM) in addition to being Scientific Director of Innate Pharma, a biotechnology company dedicated to improving cancer treatment with innovative therapeutic antibodies that exploit the immune system. Eric Vivier’s work focuses on innate immunity and in particular Natural killer and other innate lymphoid cells, at Ciml, at AP-HM and at Innate-Pharma.

MODERATOR

Miriam Merad, M.D.; Ph.D. is the Mount Sinai Chair professor in Cancer Immunology and the Director of the Precision Immunology Institute at Mount Sinai School of Medicine in New York. Dr. Merad also co-Directs, the Cancer Immunology program at The Mount Sinai Tisch Cancer Institute and is the Director of the Mount Sinai Human Immune Monitoring Center (HIMC).

Miriam Merad is the Vice-President of IUIS.

 


Event Details


Upcoming Events

Frontiers in Immunology (In-Person & Virtual)

Tuesday 11th April 2023 at New York Academy of Sciences

2023 International Day of Immunology

Saturday 29th April 2023

IUIS-SMI-FAIS Immuno-Morocco Course

Monday 5th June 2023 at Zephyr TargaTunisian Society of Immunology, Federation of African Immunological Societies (FAIS)

Memorial Symposium – Michael Sela

Wednesday 7th June 2023 at Science of Institute WeizmannIsraeli Society for Immunology

17th International Workshop on Langerhans Cells – and Related Myeloid Cells of the Skin

Thursday 8th June 2023 at Institut Cochin

FOCIS 2023 Annual Meeting

Tuesday 20th June 2023 at Boston Marriott Copley Place.

WCP2023 – 19th World Congress of Basic and Clinical Pharmacology

Sunday 2nd July 2023

Travel Award – IUIS/AAI Summer Introductory Course in Immunology

Tuesday 11th July 2023 at UCLA Meyer and Renee Luskin Conference CenterAmerican Association of Immunologists (AAI), Gender Equality Committee (GEC) and 1 more

Travel Award – IUIS/AAI Summer Advanced Course in Immunology

Sunday 23rd July 2023 at The Westin Copley PlaceAmerican Association of Immunologists (AAI), Gender Equality Committee (GEC) and 1 more